Medicine Atlas

How Healing Is Practiced
Sign In
Text size
100%
Theme
Condition

Kufs disease

Endocrine, Nutritional and Metabolic Diseases

Kufs disease, also called adult neuronal ceroid lipofuscinosis or ANCL, is a term for several rare inherited disorders in which fatty, granular pigments called ceroid and lipofuscin build up inside nerve cells of the brain and in other tissues. It belongs to the neuronal ceroid lipofuscinoses, a group of progressive, degenerative neurometabolic disorders, and is set apart by onset in adulthood, usually around the age of 30, although symptoms can begin in the teenage years or after the age of 50. The disease was historically divided into type A, associated with progressive myoclonic epilepsy, and type B, which often brings problems of movement and coordination, dementia and behavioral change, with seizures rare. Researchers now prefer to classify these disorders by the affected gene, for example CLN6 for type A and CTSF for type B. Most forms are inherited in an autosomal recessive manner, while the form caused by specific changes in the DNAJC5 gene, known as Parry disease, is autosomal dominant. No disease-specific treatment exists; care is directed at the symptoms each person has.

Facts
Classification
Body System
Nervous System 1
ICD-10 Chapter
IV: Endocrine, Nutritional and Metabolic Diseases 2
Communicable or Non-communicable
Non-Communicable 1
Transmission Route
Non-Transmissible 1
Causative Agent
Causative Agent (category)
Genetic / Hereditary 1
Sources
1. NORD Rare Disease Report on Adult Neuronal Ceroid Lipofuscinosis (Kufs disease)
  • Disease Overview, Summary
    progressive deterioration (atrophy) of certain areas of the brain, neurological impairment
  • Disease Overview, Summary [causative-agent-category]
    The ANCLs are caused by changes (mutations) in different genes
  • Disease Overview, Summary [disease-category]
    several rare genetic disorders that belong to a group of progressive, degenerative neurometabolic disorders
  • Causes
    Most types of ANCL are inherited in an autosomal recessive manner.
View the Source
2. World Health Organization: ICD-10 2019, E75 Disorders of sphingolipid metabolism and other lipid storage disorders, E75.4 Neuronal ceroid lipofuscinosis
World Health OrganizationICD-10 E75.4 for the NCL group; chapter derived from WHO range E00-E90
Quote, ICD-10 E75.4 for the NCL group; chapter derived from WHO range E00-E90
Neuronal ceroid lipofuscinosis
View the Source
Comments (0)
No comments yet. Be the first to share a thought.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.